Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Lifastuzumab [USAN]
RN: 1615697-16-9
UNII: S072MTS0FN

Molecular Formula

  • C6504-H10028-N1744-O2018-S46 (peptide)
 

Classification Code

  • Treatment of Cancer
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)

Names and Synonyms

Name of Substance

  • Lifastuzumab [USAN]

Synonyms

  • Lifastuzumab
  • MNIB2126A
  • NaPi3b
  • UNII-S072MTS0FN

Systematic Names

  • Immunoglobulin G1, anti-(human phosphate-sodium cotransporter NaPi3b) (human-Mus musculus monoclonal DNIB0600A heavy chain), disulfide with human-Mus musculus monoclonal DNIB0600A light chain, dimer
  • Immunoglobulin G1-kappa, anti-(human Sodium-dependent phosphate transport protein 2B (NaPi3b, sodium/phosphate cotransporter 2B, NaPi-2b, solute carrier family 34 member 2)), humanized mouse monoclonal antibody: gamma1 heavy chain (1-449) (humanized VH (human IGHV3-23*4 (86%) -(IGHD)-IGHJ5*01) (93%) (8.8.13) (1-120) -human IGHG1*03 (CH1 R97>K(217),CH3 K107del (450)) (121-449)) (223-219')-disulfide with kappa light chain (1'-219') (humanized V-KAPPA (human IGKV1-39*01 (78%) -IGKJ1*01) (11.3.9) (1'-112') -human IGKC*01 (113'-219')) dimer (229-229'':232-232'')-bisdisulfide

Registry Numbers

CAS Registry Number

  • 1615697-16-9

FDA UNII

  • S072MTS0FN

System Generated Number

  • 1615697169